A world-first cancer vaccine could be in the hands of those with genetic indicators in the next five years, thanks to the pandemic

The vaccine is being developed by the University of Oxford

Scientists at the University of Oxford are creating OvarianVax, a vaccine which teaches the immune system to recognise and attack the earliest stages of ovarian cancer

In this study, the Cancer Research UK-funded scientists will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most strongly recognized by the immune system and how effectively the vaccine kills mini-models of ovarian cancer called organoids.

A newly designed drug is effective against drug-sensitive and drug-resistant strains of human malaria parasites, researchers say.

A new study identified that a semi-synthetic compound can be derived from natural compounds and shows potent activity against tuberculosis (TB), including multi-drug resistant TB.